MedPath

NOCTRIX HEALTH, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Response to an Investigational Device in Patients With Restless Legs Syndrome

Not Applicable
Recruiting
Conditions
Restless Legs Syndrome
First Posted Date
2025-03-10
Last Posted Date
2025-05-22
Lead Sponsor
Noctrix Health, Inc.
Target Recruit Count
20
Registration Number
NCT06866132
Locations
🇺🇸

Noctrix Health Headquarters, Pleasanton, California, United States

A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS

Recruiting
Conditions
Restless Legs Syndrome
First Posted Date
2023-10-10
Last Posted Date
2024-02-21
Lead Sponsor
Noctrix Health, Inc.
Target Recruit Count
325
Registration Number
NCT06076499
Locations
🇺🇸

Neurocare, Inc., Newton, Massachusetts, United States

🇺🇸

Mark J Buchfuhrer, MD Office, Downey, California, United States

🇺🇸

Sleep Medicine Specialists of California, San Ramon, California, United States

and more 3 locations

Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS

Not Applicable
Completed
Conditions
Restless Legs Syndrome
Interventions
Device: NTX100 Neuromodulation System - Active
Device: NTX100 Neuromodulation System - Sham
First Posted Date
2022-01-31
Last Posted Date
2023-12-15
Lead Sponsor
Noctrix Health, Inc.
Target Recruit Count
58
Registration Number
NCT05214963
Locations
🇺🇸

SRI International Human Sleep Research Lab, Menlo Park, California, United States

🇺🇸

Sleep Medicine Specialists of California, San Ramon, California, United States

🇺🇸

Clayton Sleep Institute, Saint Louis, Missouri, United States

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

Not Applicable
Completed
Conditions
Restless Legs Syndrome
Interventions
Device: NTX100 Neuromodulation System
First Posted Date
2022-01-19
Last Posted Date
2023-01-11
Lead Sponsor
Noctrix Health, Inc.
Target Recruit Count
101
Registration Number
NCT05196828
Locations
🇺🇸

Clayton Sleep Institute, Saint Louis, Missouri, United States

🇺🇸

FutureSearch Trials of Neurology, Austin, Texas, United States

🇺🇸

Delta Waves, Inc., Colorado Springs, Colorado, United States

and more 4 locations

Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)

Not Applicable
Completed
Conditions
Restless Legs Syndrome
Interventions
Device: NTX100 Neuromodulation System - Sham
Device: NTX100 Neuromodulation System - Open-Label
Device: NTX100 Neuromodulation System - Active
First Posted Date
2021-05-05
Last Posted Date
2024-10-08
Lead Sponsor
Noctrix Health, Inc.
Target Recruit Count
133
Registration Number
NCT04874155
Locations
🇺🇸

Neurotrials Research, Atlanta, Georgia, United States

🇺🇸

Ohio Sleep Medicine Institute, Dublin, Ohio, United States

🇺🇸

Bogan Sleep Consultants, LLC, Columbia, South Carolina, United States

and more 4 locations

Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome

Not Applicable
Completed
Conditions
Restless Legs Syndrome
Interventions
Device: Noctrix Health NPNS device v1.0 - Active
Device: Noctrix Health NPNS device v1.0 - Sham
First Posted Date
2021-01-08
Last Posted Date
2021-01-08
Lead Sponsor
Noctrix Health, Inc.
Target Recruit Count
43
Registration Number
NCT04700683
Locations
🇺🇸

Mark J Buchfuhrer private practice, Downey, California, United States

🇺🇸

SRI International Human Sleep Research Lab, Menlo Park, California, United States

🇺🇸

Sleep Medicine Specialists of California, San Ramon, California, United States

Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction

Not Applicable
Completed
Conditions
Restless Legs Syndrome
Interventions
Device: Noninvasive Peripheral Nerve Stimulation (NPNS)
First Posted Date
2021-01-06
Last Posted Date
2023-06-29
Lead Sponsor
Noctrix Health, Inc.
Target Recruit Count
21
Registration Number
NCT04698343
Locations
🇺🇸

Mark J Buchfuhrer private practice, Downey, California, United States

🇺🇸

Ohio Sleep Medicine Institute, Dublin, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath